Lymphoma-Specific Questionnaire Addresses Unmet Patient Needs
Researchers developed an instrument to identify unmet needs and quality-of-life outcomes for patients with lymphoma.
Diagnosis & Disease Information
Tool Increases Patient Engagement, Safety at Bedside Handover
Results of a project to improve shift-to-shift bedside handover was described in an EONS session.
Patients With CRC Often Delay Seeking Medical Care After Symptom Onset
Researchers in Turkey explored why patients with CRC tended to delay seeking medical care after initial symptom onset.
Consent Process for Anticancer Therapy Allows Information Processing Time
Researchers developed and piloted a multistage consent process designed to ease potential communication barriers for patients considering IV cancer therapy.
Nutriscore Screening Tool Identifies Risk for Malnutrition in Newly Diagnosed CRC
Nutriscore is based on the Malnutrition Screening Tool, but also includes questions regarding tumor location and cancer-specific treatments.
Fiber and Saturated Fatty Acid Intake Affects the Efficacy of Immunotherapy
Interviews with patients revealed the dietary habits that improved response to immunotherapy for NSCLC.
TROPiCS-02: Sacituzumab Govitecan Prolongs OS in HR+/HER2- Advanced Breast Cancer
Sacituzumab govitecan improves overall survival, when compared with physician’s choice of treatment, in HR+, HER2- advanced breast cancer.
Long-Acting G-CSF May Reduce FN-Related Hospitalization in DLBCL After R-CHOP
Long-acting G-CSF can reduce the risk of hospitalization related to febrile neutropenia in patients with DLBCL treated with R-CHOP.
Vaccine-Pembrolizumab Combo Appears Active in HPV+ Advanced Cervical Cancer
Combination treatment with the GX-188E vaccine and pembrolizumab can elicit responses in patients with HPV 16-/18-positive advanced cervical cancer.
Orelabrutinib Plus RCHOP Effective for Extranodal, Non-GCB Diffuse Large B-Cell Lymphoma
The aim of this trial was to evaluate the efficacy and safety of orelabrutinib with RCHOP in patients with extranodal non-GCB DLBCL.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...